Japans national health insurance system has covered Wegovy for weight management since February 2024, but under stringent eligibility criteria and prescribing restrictions that have kept actual patient numbers limited
Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT, Anti-TNF Therapy Against Congestive Heart Failure Investigators (2003) Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF therapy against congestive heart failure (ATTACH) trial
Although clinical, empirical data guides medical practice, every patient is unique and deserves individualized considerations
The original agents, like exenatide and liraglutide, were pioneered for blood sugar control in type 2 diabetes
Increase your water intake significantly in the days leading up to your shot